Microfluid Platform to Screen Cancer Drug for Delivery
- Summary
- Researchers at Purdue University have developed a microfluidic platform to simulate a 3D tumor vasculature system. This innovative platform can mimic the complex transport processes inside a tumor, such as transvascular transport, interstitial transport, and transmembrane transport. These processes are all simulated on a single benchtop device, thus improving the repeatability and speed of testing, while reducing the cost and use of animals in drug discovery.
- Technology Benefits
- Mimics multiple transport processesIncreased repeatability and speed for drug testing Low cost
- Technology Application
- Medical/HealthPharmaceutical industry Drug developmentResearch labs
- Detailed Technology Description
- Kinam ParkPurdue Biomedical EngineeringPurdue Industrial and Physical Pharmacy
- Countries
- United States
- Application No.
- 9,081,003
- *Abstract
-
- *Background
- Developing and testing cancer drugs is an expensive process that requires, among other things, exhaustive in vivo animal experiments. One aim of preclinical animal studies is to analyze how effectively a drug is transported and delivered to its target in a tumor mass. However, animal testing can be an expensive and slow process.
- *IP Issue Date
- Jul 14, 2015
- *IP Type
- Utility
- *Stage of Development
- Concept Developed
- *Web Links
- Purdue Office of Technology CommercializationPurdueInnovation and EntrepreneurshipKinam ParkPurdue Biomedical EngineeringPurdue Industrial and Physical Pharmacy
- Country/Region
- USA
For more information, please click Here
